Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis—a proof of principle and exploratory trial: is dose tapering practical in good responders?

Necrosis Factor ◽

Proof Of Principle

Faculty Opinions recommendation of The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104777.560749 ◽

2008 ◽

Author(s):

Geoff Littlejohn

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Population Based Study ◽

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus

Rheumatology ◽

10.1093/rheumatology/key076 ◽

2018 ◽

Vol 57 (Supplement_7) ◽

pp. vii32-vii41

Author(s):

Alessandra Bortoluzzi ◽

Guido Valesini ◽

Salvatore D’Angelo ◽

Bruno Frediani ◽

Laura Bazzichi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Expert Consensus ◽

Disease Modifying ◽

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

Arthritis Research & Therapy ◽

10.1186/ar4584 ◽

2014 ◽

Vol 16 (3) ◽

pp. R127 ◽

Cited By ~ 43

Author(s):

Lotta Ljung ◽

Johan Askling ◽

Solbritt Rantapää-Dahlqvist ◽

Lennart Jacobsson ◽

Keyword(s):

Rheumatoid Arthritis ◽

Acute Coronary Syndrome ◽

Cohort Study ◽

General Population ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Coronary Syndrome ◽

National Cohort ◽

Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis

International Journal of Rheumatic Diseases ◽

10.1111/j.1756-185x.2009.01457.x ◽

2010 ◽

Vol 13 (1) ◽

pp. 12-26 ◽

Cited By ~ 15

Author(s):

Veera S. KATIKIREDDI ◽

Samuel L. WHITTLE ◽

Catherine L. HILL

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Serious Infection ◽

Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice

Clinical Rheumatology ◽

10.1007/s10067-015-2879-0 ◽

2015 ◽

Vol 34 (4) ◽

pp. 673-681 ◽

Cited By ~ 21

Author(s):

Marina Backhaus ◽

Jörg Kaufmann ◽

Constanze Richter ◽

Siegfried Wassenberg ◽

Anne-Eve Roske ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Retrospective Analysis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Routine Clinical Practice ◽

AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study:

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.526 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 668.6-668

Author(s):

E. Keystone ◽

S.B. Cohen ◽

P. Emery ◽

J.M. Kremer ◽

M. Dougados ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Safety Profile ◽

Tumour Necrosis ◽

Inadequate Response ◽

Sustained Efficacy ◽

Repeat Treatment ◽

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

The Lancet ◽

10.1016/s0140-6736(12)61424-x ◽

2013 ◽

Vol 381 (9865) ◽

pp. 451-460 ◽

Cited By ~ 393

Author(s):

Gerd R Burmester ◽

Ricardo Blanco ◽

Christina Charles-Schoeman ◽

Jürgen Wollenhaupt ◽

Cristiano Zerbini ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.098111 ◽

2008 ◽

Vol 67 (11) ◽

pp. 1497-1498 ◽

Cited By ~ 20

Author(s):

J. S Smolen ◽

M. E Weinblatt

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2011-200956 ◽

2012 ◽

Vol 71 (10) ◽

pp. 1671-1679 ◽

Cited By ~ 38

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Robert B M Landewé ◽

Eric L Matteson ◽

Norman Gaylis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Previous Experience ◽

Double Blind ◽

Double Blind Placebo ◽

The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review

Rheumatology ◽

10.1093/rheumatology/kes217 ◽

2012 ◽

Vol 51 (12) ◽

pp. 2252-2261 ◽

Cited By ~ 43

Author(s):

R. J. Moots ◽

B. Naisbett-Groet

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Biologic Agents ◽

Inadequate Response ◽